Biotechcgt
Industries

Scale advanced therapies and biotech without breaking the patient specific promise

  • Industry: Advanced Therapies and Biotech
  • Gartner™ Recognized as a Leader
  • CDMO services, Cell & Gene Therapies, Radiopharmaceuticals, Clinical to Commercial Scale-up

Scaling What Matters

Patient timing at risk from disconnected steps

Patient timing at risk from disconnected steps

Slots, collections, manufacturing, QC, QA, and release get planned separately, so vein to vein or shelf life timing isn’t protected end to end. 

Chain of identity risk hides in the schedule

Chain of identity risk hides in the schedule

A missed slot or delayed step doesn’t just cost time, it can break the link between patient and product, and standard scheduling tools weren’t built to protect that link. 

CMO and CDMO commitments locked in too early

CMO and CDMO commitments locked in too early

Capacity, sourcing, and technology transfer get committed before risk and performance data are checked.

Commercial capability built after volume arrives

Commercial capability built after volume arrives

Planning, systems, and governance get built reactively instead of ahead of the scale up. 

What We Do

Patient Specific Planning and Scheduling

QC and CGT planning and scheduling, E2E planning and scheduling, digital planning strategy and design, program management and change adoption. 

CMO and CDMO Network Orchestration

External manufacturing network extension, network decision governance, risk and resilience, network analytics and control towers. 

Data Foundations and Decision Intelligence

AI ready data foundation, data quality and master data accuracy, AI roadmap and readiness, enterprise transformation for AI.

Cold Chain and Identity Protection

Cold chain and specialist fulfillment, perfect fulfillment, integrated network operations, customer centricity

Cell and Gene Therapy Manufacturing

QC supply chain integration, external manufacturing and CDMO maturity, plant effectiveness, advanced manufacturing operator scheduling. 

Scale Up and Operating Model Readiness

Organizational transformation, change management, readiness based release management, transformation governance and business case.

Cutting X Community

Exchange Ideas with the Advanced Therapies & Biotech Community

Connect with manufacturing, quality, and supply peers scaling patient specific and commercial biotech operations, including voices from Legend Biotech, Argenx,... and see how others are protecting control while they grow.

Bluecrux binocs 17691

Built For Patient-Specific Supply

Connects supply priorities to capacity plans and schedules for QC, R&D, manufacturing, and advanced therapy operations.

Binocs™

Discover Binocs

Powers commercial biotech supply planning, connecting demand, inventory, sourcing, regulatory constraints, shelf life, scenarios, and CMO capacity. 

Helion™

Discover Helion

Join our Biotech Community

Request to Join